Overview
Updated 14 Jul 2026
Mario Lacouture, MD, is Chief, Dermatology Division, NYU Langone Hospital–Long Island at NYU Langone Health. The public record shows 703 publications with 28,964 citations (h-index 88), centered on Colorectal Cancer Treatments and Studies, Chemotherapy-related skin toxicity, Cancer Immunotherapy and Biomarkers. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 14 companies.
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Colorectal Cancer Treatments and Studies
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 19 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 283.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Sponsor: Hoth Therapeutics, Inc.
InvestigatorPhase 2RecruitingNCT05639933 - A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients
Sponsor: OnQuality Pharmaceuticals (USA) LLC
InvestigatorPhase 2UnknownNCT04088318 - Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
InvestigatorCompletedNCT03796052
Industry payments
Updated 14 Jul 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Cipher Pharmaceuticals US LLCProgram year20251 payment
- GENZYME CORPORATIONProgram year20241 payment
- Daiichi Sankyo Inc.Program year20241 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Jul 2026
137 congress contributions (2007–2026) across AACR, ASCO, ASH, ASTRO, ESMO per OpenAlex. The most recent:
- Oncologic outcomes following biologic therapy for immune-related cutaneous adverse events.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process.
Journal of the European Academy of Dermatology and Venereology
2025 - Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel.
Archives of dermatological research
2024
Most-cited worksby citation count (OpenAlex)
- 01
- 02Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies1,466 citations2015
- 03
- 04Mechanisms of cutaneous toxicities to EGFR inhibitors779 citations2006
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
1111 Franklin Avenue, Suite 1232, Garden City, NY 11530
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Editorial & leadership rolesjournal and society appointments
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodermatologysociety.org ↗
- Editor
textbook "Dermatologic Principles and Practice in Oncology"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biospace.com ↗ - Member
Guidelines Advisory Committee, American Society of Clinical Oncology (ASCO)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →biospace.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
Media & interviewspress, podcasts and appearances
- "Hair Loss? Rashes? Dr. Mario Lacouture Specializes in Easing Cancer-Treatment Side Effects"
NYU Langone News feature
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jddonline.com ↗
- "Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture"
ILCN.org (International Lung Cancer News/WCLC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ilcn.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- LinkedIn
linkedin.com/in/mario-lacouture-m-d-26811819
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/mario-lacouture-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Mario-Lacouture
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- YouTube
mskcc.org/podcasts/cancer-straight-talk/how-to-manage-side-effects-during-cancer-treatment-fatigue-hair-loss
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
- 1,922
- publications
- 126
- h-index
- 4
- trials
Ira Jacobson, MD
NYU Langone Health
- 594
- publications
- 87
- h-index
- 4
- trials
Gregory Haber, MD
NYU Langone Health
- 286
- publications
- 39
- h-index
- 8
- trials
Larry Chinitz, MD
NYU Langone Health
- 297
- publications
- 35
- h-index
- 8
- trials